NextPlat Corp (NASDAQ:NXPL) Short Interest Update

NextPlat Corp (NASDAQ:NXPLGet Free Report) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 17,700 shares, a decline of 20.3% from the October 31st total of 22,200 shares. Based on an average trading volume of 43,100 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are short sold.

NextPlat Stock Performance

NXPL opened at $0.79 on Monday. The stock’s 50 day simple moving average is $1.13 and its 200 day simple moving average is $1.15. The stock has a market cap of $20.57 million, a P/E ratio of -1.16 and a beta of 0.92. NextPlat has a 1-year low of $0.75 and a 1-year high of $2.68. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.70 and a quick ratio of 3.04.

Institutional Trading of NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Omnia Family Wealth LLC acquired a new stake in NextPlat Corp (NASDAQ:NXPLFree Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned about 0.49% of NextPlat at the end of the most recent quarter. Institutional investors and hedge funds own 1.30% of the company’s stock.

NextPlat Company Profile

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

See Also

Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.